Nephros Engages Joseph S. Cervia, M.D. As Strategic Consultant

RIVER EDGE, N.J., Nov. 21, 2011 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that the company has engaged Joseph S. Cervia, M.D. as a strategic consultant.

Joseph S. Cervia, MD, MBA, FACP, FAAP, FIDSA, AAHIVS is Clinical Professor of Medicine and Pediatrics at the Albert Einstein College of Medicine and Hofstra North Shore-LIJ School of Medicine (Division of Infectious Diseases).  From 2004 to 2011, he served as Global Medical Director and Senior Vice President for Pall Corporation (NYSE: PLL) where he was responsible for supporting all aspects of the global medical enterprise, including medical and regulatory affairs, research and development, medical marketing and communications, technology assessment, and technical support.  A board-certified internist, pediatrician, adult and pediatric infectious diseases and HIV medicine specialist, Dr. Cervia has dedicated much of his career to establishing and leading multi-disciplinary teams in battling infectious diseases, and to education and research in prevention, therapeutics, complicating illnesses, and quality of life issues.  He has authored over 100 peer-reviewed articles, chapters, and abstracts; lectures widely; and serves as a consultant to numerous local, national, and international organizations on HIV, infectious diseases, and other health care-related issues.  Dr. Cervia earned his B.S. in biology from St. Johns University, his M.D. degree from New York Medical College, and an MBA degree from Regis University.  He is a board-certified diplomate in five medical specialties: Internal Medicine, Pediatrics, Adult Infectious Diseases, Pediatric Infectious Diseases and HIV Medicine.



"Nephros has a leading edge line of ultrafiltration products which addresses many important applications in which biological contaminants must be removed from fluid," said Dr. Cervia.  "I look forward to working with Nephros to increase market awareness and adoption of the company's products."

1 2 3 4 Next › Last »